
Add to Cart
LGD-4033 (VK5211, Ligandrol) is an investigational selective androgen receptor modulator for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics